Primary Recipient

MOLECULAR INSIGHT PHARMACEUTICALS, INC.

Amount

$243,101.00

Award Date

9/01/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Determination of serum prostate specific antigen (PSA) is an effective early screen for potential Prostate cancer with revenues estimated at over $350 million annually. Although the current screening method of PSA levels in the blood is valuable for early